FDA Inspection 1224701 — Medsource Pharmaceuticals

Medsource Pharmaceuticals — FEI 3007422897

The FDA completed an inspection of Medsource Pharmaceuticals on December 11, 2023 in Rancho Santa Margarita, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 11, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rancho Santa Margarita, CA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
434221 CFR 211.142(b)Storage under appropriate conditions